The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors

  • Lloyd J. Simons
  • , Bradley W. Caprathe
  • , Michael Callahan
  • , James M. Graham
  • , Takenori Kimura
  • , Yingjie Lai
  • , Harry LeVine
  • , William Lipinski
  • , Annette T. Sakkab
  • , Yoshikazu Tasaki
  • , Lary C. Walker
  • , Tomoyuki Yasunaga
  • , Yuyang Ye
  • , Nian Zhuang
  • , Corinne E. Augelli-Szafran

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Abstract

It is believed that β-amyloid aggregation is an important event in the development of Alzheimer's disease. In the course of our studies to identify β-amyloid aggregation inhibitors, a series of N-phenyl anthranilic acid analogs were synthesized and studied for β-amyloid inhibition activity. The synthesis, structure-activity relationship, and in vivo activity of these analogs are discussed.

Original languageEnglish
Pages (from-to)654-657
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number3
DOIs
StatePublished - Feb 1 2009

Keywords

  • Alzheimer's disease
  • Amyloid aggregation
  • Amyloid aggregation inhibitors
  • Amyloid plaques
  • Analogs
  • Beta-amyloid
  • Hsiao mouse model
  • N-Phenyl anthranilic acid
  • Tg2576 mice

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors'. Together they form a unique fingerprint.

Cite this